1. Home
  2. BFC vs IOVA Comparison

BFC vs IOVA Comparison

Compare BFC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$155.29

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.32

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
IOVA
Founded
1894
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
BFC
IOVA
Price
$155.29
$4.32
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
$157.00
$9.00
AVG Volume (30 Days)
82.1K
15.7M
Earning Date
04-16-2026
05-07-2026
Dividend Yield
1.52%
N/A
EPS Growth
11.23
14.84
EPS
1.78
N/A
Revenue
N/A
N/A
Revenue This Year
$58.67
$47.74
Revenue Next Year
$2.01
$40.31
P/E Ratio
$85.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$115.29
$1.76
52 Week High
$154.42
$5.64

Technical Indicators

Market Signals
Indicator
BFC
IOVA
Relative Strength Index (RSI) 64.11 46.11
Support Level $134.81 $3.51
Resistance Level N/A $4.45
Average True Range (ATR) 4.97 0.45
MACD 0.53 -0.10
Stochastic Oscillator 91.09 28.72

Price Performance

Historical Comparison
BFC
IOVA

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: